Synergy Pharmaceuticals, Inc. Files Suit Against Ironwood Pharmaceuticals, Inc. & its Chief Scientific Officer & Senior VP of...
2011年12月13日 - 5:00PM
ビジネスワイヤ(英語)
Synergy Pharmaceuticals, Inc. (Nasdaq:SGYPD, SGYPU), a developer
of new drugs to treat gastrointestinal (GI) disorders and diseases,
announced today that it has filed a lawsuit in New York State
Supreme Court against Ironwood Pharmaceuticals, Inc. (Nasdaq:IRWD)
and its Chief Scientific Officer and Senior VP of R&D, Dr. Mark
G. Currie.
The lawsuit alleges that after European patent 1,379,224 was
granted to Synergy but prior to issuance, Ironwood and Dr. Currie
opposed the patent before the European Patent Office and presented
to the European Patent Office and the United States Patent and
Trademark Office, data and arguments that were false,
contradictory, inaccurate and misleading. In its complaint, Synergy
accuses Ironwood and Dr. Currie of, among other things, unfair
competition, fraud and unjust enrichment and seeks $500 million in
actual and punitive damages.
About Synergy Pharmaceuticals, Inc.
Synergy is a biopharmaceutical company focused on the
development of new drugs to treat gastrointestinal disorders and
diseases. Synergy's proprietary drug candidate plecanatide is a
synthetic analog of the human gastrointestinal hormone uroguanylin,
and functions by activating the guanylate cyclase C receptor on
epithelial cells of the GI tract. Synergy completed a Phase I study
of plecanatide in healthy volunteers and a Phase IIa clinical trial
in patients to treat chronic idiopathic constipation (CIC)
patients. In October 2011, Synergy initiated dosing of patients in
a major Phase II/III clinical trial of plecanatide in CIC patients.
Plecanatide is also being developed to treat
constipation-predominant irritable bowel syndrome, with the first
trial in IBS-C patients planned for 2012. Synergy’s second GC-C
agonist SP-333 is currently in pre-clinical development to treat
inflammatory bowel diseases. More information is available at
http://www.synergypharma.com.
Synergy Pharmaceuticals, Inc. (MM) (NASDAQ:SGYPD)
過去 株価チャート
から 9 2024 まで 10 2024
Synergy Pharmaceuticals, Inc. (MM) (NASDAQ:SGYPD)
過去 株価チャート
から 10 2023 まで 10 2024
Real-Time news about Synergy Pharmaceuticals, Inc. (MM) (ナスダック市場): 0 recent articles
その他のSynergy Pharmaceuticals, Inc.ニュース記事